Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses

Thorax

Volumn 53, Issue 4, 1998, Pages 302-307

  Andersen, Paul ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIACEAE; HISTOPATHOLOGY; LEGIONELLA; LOWER RESPIRATORY TRACT INFECTION; MYCOPLASMA; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 0031924891     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.4.302     Document Type: Review

References (93)

1. Henderson FW, Clyde WA, Collier AM, et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 1979;95:183 90.
2. Denny FW. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 1995;152:s4 12.
3. Denny FW, Clyde WA, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology and control. J Infect Dis 1971;123:74 92.
4. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia penumoniae causes pneumonia and bronchitis. J Infect Dis 1993;168:1231 5.
5. Falck G, Heyman L, Gnarpe J, et al. Chlamydia pneumoniac (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994;26:179 87.
6. Hahn DI., Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (Strain TWAR) infection with wheezing, asthmatic bronchitis, adult-onset asthma. JAMA 1991;266:225 30.
7. Becroft DMO. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol 1971;24:72 82.
8. Winterbauer RH, Ludwig WR, Hamman SP. Clinical course, management and long-term sequelae of respiratory failure due to influenza viral pneumonia. Johns Hopkins Med J 1977;141:148 55.
9. Barker DJP, Osmond C. Childhood respiratory infection and adult chronic bronchitis in England and Wales. BMJ 1980;293:1271 8.
10. Chastre J, Raghu G, Soler P, et al. Pulmonary fibrosis following pneumonia due to acute Legionnaires' disease. Chest 1987;91:57 62.
11. Cassell GH, Cole BC. Mycoplasmas as agents of human disease. N Engl J Med 1981;304:80-9.
12. Sims DG, Gardner PS, Weightman D, et al. Atopy does not predispose to RSV bronhiolitis or postbronchiolitic wheezing. BMJ 1981;282:2086 8.
13. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies alter respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. J Pediatr 1995;95:500 5.
14. Boldy DAR, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Rcspir Med 1990;84:377 85.
15. Thom DH, Grayston JT, Campbell LA, et al. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 1994; 13:785 92.
16. Monto AS, Cavallaro JJ. The Tecumseh study of respiratory illness. Am J Epidemiol 1971;94:280 -289.
17. Leigh MW, Clyde WA. Chlamydial and mycoplasmal pneumonias. Semin Respir Infect 1987;2:152-8.
18. Powell DA, Hu PC, Wilson M, et al. Attachment of Mycoplasma pneumoniae to respiratory epithelium, Infect Immun 1976,13:956-66.
19. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-47.
20. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994;58:686-99.
21. Svanborg C, Agace W, Hedges S, et al. Bacterial adherence and epithelial cell cytokine production. Zbl Bakt 1993;278: 359-64.
22. Loosli SG, Stinson SF, Ryan DP, et al. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus: its effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest 1975;67(suppl 2):7s-14s.
23. Winther B, Farr B, Turner RB, et al. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol 1984;Suppl 413:19-24.
24. Huhti E, Mokka T, Nikoskelainen J, et al. Association of viral and mycoplasma infections with exacerbations of asthma. Ann Allergy 1974;33:145-9.
25. Little JW, Hall WJ, Douglas RG, et al. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 1978;118:295-303.
26. Johnston SL, Pattemore PH, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995,310:1225-9.
27. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6.
28. Empey DW, Laitinen LA, Jacobs L, et al. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113: 131-9.
29. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasophagyngeal secretions after infection. N Engl J Med 1981;305:841-6.
30. Welliver RC, Wong DT, Sun M, et al. Parainfluenza virus bronchiolitis. Am J Dis Child 1986;14:34-40.
31. Frydén A, Kihlström E, Maller R, et al. A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (Strain TWAR). Scand J Infect Dis 1989;21:681-91.
32. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178 82.
33. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727 32.
34. Allegra L, Blasi F, Centanni S, et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 1994;7:2165 8.
35. Emre U, Sokolowskaya N, Roblin PM, et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995;172:265 7.
36. Campbell IA, Kuo CC, Wong SP, et al. Serological response to Chlamydia pneumoniae infection. J Clin Microbiol 1990;28:1261 4.
37. Bavastrelli M, Midulla M, Rossi D, et al. Chlamydia trachomatis infection in children with wheezing simulating asthma. Lancer 1992;339:1174.
38. Carballal G, Mahony JB, Videla C, et al. Chlamydial antibodies in children with lower respiratory disease. Pediatr Infect Dis J 1992;11:68 71.
39. Ragunathan PL, Gray JW, Kenna AP, et al. No evidence of Chlamydia trachomatis infection in children with wheeze. Eur J Clin Microbiol Infect Dis 1995;14:470 1.
40. Gil JC, Cedillo RL, Mayagoitia BG, et al. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993,70:23-5.
41. Nagayama Y, Sakurai N, Yamamoto K, et al. Isolation of Mycoplasma pneumoniae from children with lower respiratory tract infections. J Infect Dis 1988;157:911 17.
42. Seggev JS, Lis I, Siman-Tou R, et al. Mycoplasma pneumoniae is a cause of exacerbation of bronchial asthma in adults. Ann Allergy 1986;57:263 5.
43. Tipirneni P, Moore BS, Hyde JS, et al. IgE antibodies to Mycoplasma pneumoniae in asthma and other atopic diseases. Ann Allergy 1980;45:1 7.
44. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol 1971; 8:1319 33.
45. Winn WC, Myerowitz RL. The pathology of the Legionella pneumonias. Hum Pathol 1981;12:401 22.
46. Aherne W, Bird T, Court SDM, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970;23:7-18.
47. Kapikian AZ, Mitchell RH, Chanock RM, et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969,89:405 21.
48. Murphy BR, Prince GA, Walsh EE, et al. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 1986;24:197 202.
49. Alwan WH, Koslowska WJ, Openshaw PJM. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994;179:81-7.
50. Openshaw PJM. Immunity and immunopathology to respiratory syncytial virus. Am J Respir Crit Care Med 1995;152: s59-s62.
51. Street NE, Schumacher JH, Fong AT, et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of ThI and Th2 cells. J Immunol 1990;144:1629-39.
52. Garofalo R, Kimpen JLL, Welliver RC, et al.Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992;120:28-32.
53. Volovitz B, Welliver RC, De Castro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24:504-7.
54. Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr 1986; 109:776-80.
55. Busse WW. The relationship between viral infections and onset of allergic diseases and asthma. Clin Exp Allergy 1989;19:1-9.
56. Nielsen SL, Rønholm E, Sørensen I, et al. Improvement of serological diagnosis of neonatal cytomegalovirus infection by simultaneously testing for specific immunoglobulins E and M by antibody-capture enzyme-linked immunosorbent assay. J Clin Microbiol 1987;25:1406-10.
57. Lebowitz MD, Burrows B. The relationship of acute respiratory illness history to the prevalence and incidence of obstructive lung disorders. Am J Epidemiol 1977;105: 544-54.
58. Husby S, Agertoft L, Mortensen S, et al. Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Arch Dis Child 1993;68:352-5.
59. Macfarlane JT, Finch RG, Ward MJ, et al. Hospital study of adult community-acquired pneumonia. Lancet 1982;ii: 255-8.
60. Østergaard L, Andersen PL. Etiology of community-acquired pneumonia. Chest 1993;104:1400-7.
61. Berntsson E, Lagergård T, Strannegård Ö, et al. Etiology of community-acquired pneumonia in outpatients. Eur J Clin Microbiol 1986;5:446-7.
62. Saikku P, Wang SP, Kleemola M, et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985;151:832-9.
63. Komaroff AL, Aronson MD, Schacter J. Chlamydia trachomatis infection in adults with community-acquired pneumonia. JAMA 1981;245:1319-22.
64. Ridgway G. TWAR and changing respiratory infections. Practitioner 1990;234:790-2.
65. Erntell M, Ljunggren K, Gadd T, et al. Erythema nodosum - a manifestation of Chlamydia pneumoniae (strain TWAR) infection. Scand J Infect Dis 1989;21:693-6.
66. Shapiro DS, Kenney SC, Johnson M, et al. Brief report: Chlamydia psittaci endocarditis diagnosed by blood culture. N Engl J Med 1992;326:1192-5.
67. Jeffrey RF, More IAR, Carrington D, et al. Acute glomerulonephritis following infection with Chlamydia psittaci. Am J Kidney Dis 1992;1:94-6.
68. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis ocular hypersensitivity elicited by a genus-specific 57 kD protein. J Exp Med 1989;169:663-75.
69. Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1987;82:104-9.
70. Holt S, Ryan WF, Epstein EJ. Severe Mycoplasma pneumoniae. Thorax 1977;32:112 5.
71. Noriega ER, Simberkoff MF, Gilroy FJ. Lite-threatening Mycoplasma pneumoniae pneumonia. JAMA 1974;229: 1471-2.
72. Foy HM, Ochs H, Davis SD, et al. Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis 1973;127:388 93.
73. Ruuth E, Praz F. Interaction between mycoplasmas and the immune system. Immunol Rev 1989;112:133 60.
74. Biberfeld G, Norberg R. Circulating immune complexes in mycoplasma infection. J Immunol 1974;112:413 5.
75. Cimolai N, Wensley D, Seear M, et al. Mycoplasma pneumoniae as a cofactor in severe respiratory infections, Clin Infect Dis 1995;21:1182-5.
76. Breiman RF, Fields BS, Sanden GN, et at. Association of shower use with Legionnaires' disease. JAMA 1990;263: 2924-6.
77. Yu VL. Could aspiration be the major mode of transmission for legionella? Am J Med 1993;95:13-5.
78. Bridge JA, Edelstein PH. Oropharyngeal colonization with Legionella pneumophila. J Clin Microbiol 1983;18:1108 12.
79. Baskerville A, Fitzgeorge B, Broster M, et al. Histopathology of experimental Legionnaires' disease in guinea pigs, rhesus monkeys and marmosets. J Pathol 1983;139:349 62.
80. Davis GS, Winn WC, Gump DW, et al. Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats. Am Rev Respir Dis 1982;126:1050-7.
81. Hacker J, Ott M, Wintermeyer E, et al. Analysis of virulence factor of Legionella pneumophila. Zbl Bakt 1993;278:348 58.
82. Rodgers FG. The role of structure and invasiveness on the pathogenicity of Legionella. Zbl Bakt Hyg I Abt Orig 1983;A255:138-44.
83. Rechnitzer C. Pathogenetic aspects of Legionnaires' disease: interaction of Legionella pneumophila with cellular host defences. Acta Path Microbiol Immunol Scand 1994; 102(Suppl 43):7-43
84. Rechnitzer C, Kharazmi A. Effect of Legionella pneumophila cytotoxic protease on human neutrophil and monocyte function. Microbiol Pathol 1992;12:115 25.
85. Horwitz MA. Cell-mediated immunity in Legionnaires' disease. J Clin Invest 1983;71:1686-97.
86. Cianciotto NP, Eisenstein BI, Mody HC, et al. A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J Infect Dis 1990;162:121 6.
87. Friedman RL, Lochner JE, Bigley RH, et al. The effects of Legionella pneumophila toxin on oxidative processes and bacterial killing of human polymorphonuclear leukocytes. J Infect Dis 1982;146:328-34.
88. Hurley MC, Balaazorich K, Albano M, et al. Legionella pneumophila Mip inhibits protein kinase C. In: Barbaree JM, Breiman RF, Dufour AP, eds. Legionella. Current status and emerging perspectives. Washington: Am Soc Microbiol 1993: 69-70.
89. Locksley RM, Jacobs RF, Wilson CB, et al. Susceptibility of Legionell pneumophila to oxygen-dependent systems. J Immunol 1982;129:2192-7.
90. Shah A, Check F, Baskin S, et al. Legionnaires' disease and acute renal failure: case report and review, Clin Infect Dis 1992;14:204-7.
91. Hubbard RB, Mathur RM, MacFarlane JT. Severe community-acquired Legionella pneumonia: treatment, complications and outcome. Q J Med 1993;86:327 32.
92. Simila S, Linna O, Lanning P, et al. Chronic lung damage caused by adenovirus 7: a ten-year follow-up study Chest 1981;80:127-31.
93. Bowmann P, Wilt JC, Sayed H. Chronicity and recurrence of psittacocis. Can J Publ Health 1973;64:.167 73.